This is an ongoing educational series brought to you by EUBREAST. This year it will consist of three live webinars which will then be made available on demand. These webinars are free-of-charge but registration is required.
With special thanks to our sponsors:
Main Sponsor: MSD
Co-Sponsor: Sirius Medical
Webinar 1: Challenges in primary systemic therapy and axillary treatment in metaplastic and rare triple negative disease on 18 June 2026 – 18.00 CEST
Register here to watch on-demand: Kurs: Challenges in primary systemic therapy and axillary treatment in metaplastic and rare triple negative disease
Webinar Two: High-risk ER-positive breast cases: surgery or systemic therapy first on 10 September 2026 from 18-19.00 CEST
Register here to watch on-demand: Course: High-risk ER-positive breast cases: surgery or sytemic therapy first?
Webinar Three: Can we reduce the surgical extent (breast and axilla) after primary systemic therapy in patients with inflammatory breast cancer? on 19 November 2026 from 18-19.00 CET
Link on its way!
